≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Embolic stroke

Endpoint Browser PheWeb

I9_STR_EMBOLIC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — I63.1
  • Hospital discharge: ICD-9 — 4341A
  • Hospital discharge: ICD-8 — 43400|43499
  • Cause of death: ICD-10 — I63.1
  • Cause of death: ICD-9 — 4341A
  • Cause of death: ICD-8 — 43400|43499

2 out of 7 registries used, show all original rules.

1863

4. Check minimum number of events

None

1863

5. Include endpoints

None

1863

6. Filter based on genotype QC (FinnGen only)

1863

Control definitions (FinnGen only)

Control exclude
I9_CEREBVASC

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF6

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 28696 13054 14985
Only index persons 13155 5750 7405
Unadjusted period prevalence (%)
Whole population 0.40 0.37 0.42
Only index persons 0.25 0.21 0.28
Median age at first event (years)
Whole population 72.78 75.89 70.17
Only index persons 71.63 74.92 69.08

-FinnGen-

Key figures

All Female Male
Number of individuals 1863 604 1259
Unadjusted period prevalence (%) 0.44 0.21 0.56
Median age at first event (years) 70.19 70.38 70.11

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1697
Matched controls
16963
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
+∞
323.0
310
*
I63.1
ICD-10 Finland
Cerebral infarction due to embolism of precerebral arteries
+∞
323.0
1430
*
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
391.8
323.0
821
40
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
842.4
323.0
974
27
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
1165.7
306.8
291
*
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
3208.5
300.9
282
*
4341A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral embolism
+∞
241.4
226
*
K90
ICPC
Stroke/cerebrovascular accident
59.4
219.6
258
51
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
1103.7
204.4
196
*
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
312.9
194.3
194
7
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
11.4
185.8
373
409
AA1AD
NOMESCO Finland
CT of head and brain
5.2
185.6
754
2275
B01AA03
ATC
warfarin; systemic
4.1
155.8
863
3382
PAN14
NOMESCO Finland
Plastic repair of arteries internal carotid artery
1229.7
119.2
115
*
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
14.0
118.3
210
169
I63.2
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries
1172.4
113.9
110
*
R4120
NOMESCO Finland
Occupational therapy
10.1
113.3
237
267
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
6.3
112.6
329
621
XA800
NOMESCO Finland
Neuropsychological investigation
19.6
111.1
172
97
B01AC04
ATC
clopidogrel; oral
3.7
100.3
540
1892
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
8.8
94.7
214
273
I48
ICD-10 Finland
Atrial fibrillation and flutter
3.0
94.5
801
3881
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
32.8
81.7
108
35
AAL10
NOMESCO Finland
Intracranial endovascular thrombolysis
+∞
80.8
77
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.2
78.7
502
1944
PA2VT
NOMESCO Finland
Intravascular evacuation of brain artery embolus
+∞
71.3
68
*
C10AA05
ATC
atorvastatin; oral
2.5
67.2
822
4643
4340A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral thrombosis
+∞
67.1
64
*
K91
ICPC
Cerebrovascular disease
34.8
63.8
83
25
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
7.4
60.5
151
221
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
+∞
58.6
56
*
N18
ICPC
Paralysis/weakness
18.5
57.7
90
51
I63.8
ICD-10 Finland
Other cerebral infarction
565.2
55.9
55
*
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
4.6
52.6
194
458
H53.4
ICD-10 Finland
Visual field defects
13.6
52.2
92
71
I63
ICD-10 Finland
Cerebral infarction
85.7
52.2
58
7
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
52.0
396
1661
4380A
ICD-9 Finland
Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]
+∞
51.3
49
*
207
Kela drug reimbursment
Chronic arrhythmias
2.6
48.7
448
2086
AA5PD
NOMESCO Finland
CT examination of brain pefusion
41.4
48.1
60
15
TPX22
NOMESCO Finland
Intravenous arterial thrombolysis
56.7
46.7
55
10
B01AC07
ATC
dipyridamole; systemic
3.8
46.3
212
610
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
+∞
46.0
44
*
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
235.9
45.1
46
*
XF400
NOMESCO Finland
ECG with 12 standard connections
2.5
43.4
410
1919
R47.0
ICD-10 Finland
Dysphasia and aphasia
29.9
43.2
58
20
PA7BD
NOMESCO Finland
CT angiography of neck and brain
14.6
42.9
73
52
WX892
NOMESCO Finland
Monitored bed care
3.6
41.5
207
637
C07AB07
ATC
bisoprolol; oral
2.0
41.5
990
6959
C01AA05
ATC
digoxin; systemic
2.6
41.1
356
1585
R4150
NOMESCO Finland
Neuropsychological rehabilitation
78.8
41.0
46
6
C03CA01
ATC
furosemide; systemic
2.0
40.7
811
5292
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.7
40.7
320
1344
R1260
NOMESCO Finland
Evaluation of communicative skills
11.1
40.5
78
73
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
10.2
39.2
79
81
C09AA05
ATC
ramipril; oral
2.1
38.4
585
3401
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
17.4
37.3
59
35
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
374.7
37.1
37
*
43499
ICD-8 Finland
Cerebral embolism, Without mention of hypertension
+∞
36.6
35
*
R4130
NOMESCO Finland
Speech therapy
9.3
36.4
77
86
R4110
NOMESCO Finland
Physiotherapy
2.2
36.4
468
2515
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.3
36.1
412
2096
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
99.6
35.8
39
*
N19
ICPC
Speech disorder
21.4
35.4
52
25
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
4.8
35.0
123
274
K78
ICPC
Atrial fibrillation/flutter
2.7
32.1
247
1014
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.7
31.7
147
424
205
Kela drug reimbursment
Chronic hypertension
1.9
31.3
676
4407
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
2.2
30.0
362
1869
I10
ICD-10 Finland
Essential (primary) hypertension
1.8
28.9
1085
8407
4273A
ICD-9 Finland
Cardiac dysrhythmias, Atrial fibrillation and flutter
3.9
28.9
125
340
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
44.5
28.7
35
8
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.9
28.5
604
3874
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
16.4
28.1
45
28
C10AA01
ATC
simvastatin; oral
1.8
28.0
877
6387
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.9
27.5
180
667
I64
ICD-10 Finland
Stroke, not specified as haemorrhage or infarction
76.3
26.8
30
*
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
274.8
26.8
27
*
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
2.2
26.0
317
1633
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.9
25.1
479
2936
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
+∞
25.0
24
*
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
5.2
24.8
79
159
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
24.5
302
1558
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
2.5
24.5
211
917
G46.4*I67.9
ICD-10 Finland
Cerebellar stroke syndrome
242.9
23.7
24
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
8.6
23.4
51
61
N03AF02
ATC
oxcarbazepine; oral
5.8
23.4
67
119
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
2.0
23.2
360
2037
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
4.7
23.2
81
180
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
54.7
23.1
27
5
I50.9
ICD-10 Finland
Heart failure, unspecified
1.9
23.0
414
2473
C01DA14
ATC
isosorbide mononitrate; oral
1.8
22.9
473
2965
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
22.4
559
3713
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
22.0
398
2378
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
+∞
21.9
21
*
TKC20
NOMESCO Finland
Catheterisation of bladder
2.5
21.5
185
802
I50.0
ICD-10 Finland
Congestive heart failure
2.2
21.4
250
1255
C08CA01
ATC
amlodipine; oral
1.7
21.2
664
4697
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
21.0
371
2189
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
9.0
20.9
44
50
43399
ICD-8 Finland
Cerebral thrombosis, Without mention of hypertension
+∞
20.9
20
*
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
+∞
20.9
20
*
R51.80
ICD-10 Finland
Headache
2.4
20.4
180
790
43400
ICD-8 Finland
Cerebral embolism, With hypertension (benign)
+∞
19.8
19
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.1
19.6
112
378
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.5
19.4
93
277
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.2
19.3
216
1062
A28
ICPC
Limited function/disability NOS
1.9
19.1
346
2055
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.9
18.8
313
1804
PA6AD
NOMESCO Finland
CT of neck arteries
9.4
18.6
38
41
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.7
18.6
526
3583
B01AF02
ATC
apixaban; oral
2.1
18.4
223
1132
N03AX14
ATC
levetiracetam; systemic
5.9
18.2
51
89
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
18.0
190
908
C07AB02
ATC
metoprolol; systemic
1.7
17.7
477
3197
I69.8
ICD-10 Finland
Sequelae of other and unspecified cerebrovascular diseases
95.9
17.6
19
*
Q21.11
ICD-10 Finland
Paten or persistent foramen ovale
181.5
17.5
18
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
17.5
723
5423
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.1
17.4
68
170
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
6.6
17.2
44
68
R42
ICD-10 Finland
Dizziness and giddiness
1.8
17.2
377
2373
WX872
NOMESCO Finland
Intensive care
2.9
17.1
107
383
Z50.5
ICD-10 Finland
Speech therapy
8.4
17.0
37
45
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
16.8
197
984
81
HP
Angiography of the heart and coronary arteries
2.1
16.8
199
998
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
12.2
16.8
30
25
103
Kela drug reimbursment
Diabetes, insulin-treated
1.6
16.5
515
3582
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.6
16.1
502
3487
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
47.9
16.0
19
*
PA6BG
NOMESCO Finland
MRI examination of neck vasculature with high intensity magnet
24.7
16.0
22
9
WX882
NOMESCO Finland
High dependency care
3.9
15.9
65
170
WX002
NOMESCO Finland
Sedation and analgesia
1.8
15.8
318
1942
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.4
15.7
137
598
4331A
ICD-9 Finland
Occlusion and stenosis of precerebral arteries, Carotid artery[OCCL/STENOSIS ARTERIAE CAROTIS CUM INFARCTU CEREBRI]
+∞
15.6
15
*
N03AG01
ATC
valproic acid; systemic, rectal
3.1
15.5
86
286
B01AB05
ATC
enoxaparin; parenteral
1.6
15.5
478
3300
315
Kela drug reimbursment
Clopidogrel
6.5
15.5
40
63
XF404
NOMESCO Finland
Ambulatory ECG
2.1
15.1
177
886
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
2.8
14.7
94
342
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.6
14.4
451
3119
C07AA07
ATC
sotalol; systemic
2.4
14.2
121
520
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
4.8
14.1
46
97
I25.2
ICD-10 Finland
Old myocardial infarction
2.0
14.1
201
1087
C09AA02
ATC
enalapril; systemic
1.6
14.1
415
2823
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
8.9
14.0
29
33
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.3
13.8
127
568
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.5
13.7
107
440
4019X
ICD-9 Finland
Essential hypertension, Unspecified
2.6
13.7
103
415
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.5
13.6
523
3791
C10AX09
ATC
ezetimibe; oral
2.0
13.4
171
887
L28
ICPC
Limited function/disability (L)
1.7
13.3
292
1825
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
11.6
13.3
24
21
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
13.2
373
2502
PWE00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of peripheral vessels and lymphatic system
9.7
13.2
26
27
G81.9
ICD-10 Finland
Hemiplegia, unspecified
12.2
13.1
23
19
R47.1
ICD-10 Finland
Dysarthria and anarthria
8.3
13.0
28
34
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.8
12.8
220
1268
I61.3
ICD-10 Finland
Intracerebral haemorrhage in brain stem
+∞
12.5
12
*
PA2AC
NOMESCO Finland
Cerebral angiography with X-ray
+∞
12.5
12
*
I62.0
ICD-10 Finland
Nontraumatic subdural haemorrhage
130.7
12.4
13
*
I65.3
ICD-10 Finland
Occlusion and stenosis of multiple and bilateral precerebral arteries
130.7
12.4
13
*
F01.9
ICD-10 Finland
Vascular dementia, unspecified
3.7
12.3
52
142
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
2.1
11.9
130
632
PA2AD
NOMESCO Finland
CT angiography of brain
46.9
11.9
14
*
I69
ICD-10 Finland
Sequelae of cerebrovascular disease
46.9
11.9
14
*
AN1
HP
Coronary angiography
1.7
11.7
261
1635
5541
FHL
Subclavia and / or carotid endarterectomy, reconstruction or bypass surgery
30.2
11.6
15
5
A10BA02
ATC
metformin; oral
1.5
11.6
494
3636
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
5.0
11.6
36
73
201
Kela drug reimbursment
Chronic cardiac insufficiency
1.9
11.5
164
883
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.0
11.5
152
795
RS222
NOMESCO Finland
NA
5.5
11.5
33
61
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.6
11.5
81
317
I60.1
ICD-10 Finland
Subarachnoid haemorrhage from middle cerebral artery
+∞
11.5
11
*
4349A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral artery occlusion, unspecified[OCCL/STENOS ARTER.CEREBRALES NUD CUM INFARCTU CEREB]
+∞
11.5
11
*
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
2.0
11.5
158
844
WX730
NOMESCO Finland
Conventional respirator
4.3
11.2
41
98
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
3.1
11.2
62
208
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
6.2
11.2
29
47
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
11.2
11.0
20
18
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
60.3
10.6
12
*
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
2.1
10.6
122
606
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.1
10.5
122
608
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
10.5
239
1506
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.5
10.4
530
4032
42792
ICD-8 Finland
Symptomatic heart disease, Fibrillatio auricularis
3.5
10.4
47
136
I65.9
ICD-10 Finland
Occlusion and stenosis of unspecified precerebral artery
110.5
10.4
11
*
RL110
NOMESCO Finland
NA
+∞
10.4
10
*
I60.0
ICD-10 Finland
Subarachnoid haemorrhage from carotid siphon and bifurcation
+∞
10.4
10
*
G46.3*I67.9
ICD-10 Finland
Brain stem stroke syndrome (I60-I67+)
+∞
10.4
10
*
PA2YT
NOMESCO Finland
Cerebral artery PTA with stent
+∞
10.4
10
*
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.8
10.4
199
1190
ZXA05
NOMESCO Finland
Left side
1.5
10.3
423
3081
A06AD11
ATC
lactulose; oral
1.6
10.2
321
2196
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
10.2
244
1557
R53
ICD-10 Finland
Malaise and fatigue
1.6
10.1
320
2191
ZX120
NOMESCO Finland
Intravenous
1.9
10.1
155
861
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.4
10.0
84
361
N28
ICPC
Limited function/disability (N)
4.2
9.9
36
87
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
6.0
9.8
26
44
C03DA01
ATC
spironolactone; oral
1.7
9.8
217
1355
K89
ICPC
Transient cerebral ischaemia
5.7
9.8
27
48
N06AB04
ATC
citalopram; systemic
1.6
9.7
292
1972
K99
ICPC
Cardiovascular disease other
2.8
9.7
62
229
PA6YT
NOMESCO Finland
Dilatation of carotid artery with stent
55.2
9.6
11
*
A12BA01
ATC
potassium chloride; oral
1.9
9.6
132
705
280
Kela drug reimbursment
Clopidogrel
3.4
9.6
45
135
C01BD01
ATC
amiodarone; systemic
2.6
9.6
68
267
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
15.1
9.5
15
10
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.8
9.5
157
894
PAF12
NOMESCO Finland
Thrombendarterectomy of common carotid artery
+∞
9.4
9
*
4331X
ICD-9 Finland
Occlusion and stenosis of precerebral arteries, Carotid artery[OCCL/STENOSIS ARTERIAE CAROTIS SINE INFARCTU CEREBR]
+∞
9.4
9
*
N02BE01
ATC
paracetamol; systemic, rectal
1.4
9.3
1254
11279
M01AH05
ATC
etoricoxib; oral
0.7
9.2
434
5565
A10BB01
ATC
glibenclamide; oral
1.9
9.2
132
716
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.1
9.1
103
508
M01AE01
ATC
ibuprofen; systemic, rectal
0.7
9.1
942
10704
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
2.9
9.1
53
185
TFP20
NOMESCO Finland
Cardiodefibrillation
1.8
9.1
152
870
I67.2
ICD-10 Finland
Cerebral atherosclerosis
15.6
9.0
14
9
ZXA00
NOMESCO Finland
Right side
1.4
9.0
430
3214
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.9
8.9
140
784
Z72.0
ICD-10 Finland
Tobacco use
4.0
8.8
34
87
N03AF01
ATC
carbamazepine; oral, rectal
2.2
8.8
84
385
A10BB12
ATC
glimepiride; oral
1.7
8.6
167
1002
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
2.9
8.6
50
175
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.1
8.6
95
467
R41.0
ICD-10 Finland
Disorientation, unspecified
2.4
8.5
68
284
RS122
NOMESCO Finland
NA
27.6
8.5
11
*
H34.1
ICD-10 Finland
Central retinal artery occlusion
6.4
8.5
21
33
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.8
8.4
153
899
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.0
8.4
102
520
4100X
ICD-9 Finland
Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]
2.2
8.3
79
363
K92.1
ICD-10 Finland
Melaena
2.0
8.3
104
537
I65.0
ICD-10 Finland
Occlusion and stenosis of vertebral artery
+∞
8.3
8
*
J63.1
ICD-10 Finland
Bauxite fibrosis (of lung)
+∞
8.3
8
*
I65.1
ICD-10 Finland
Occlusion and stenosis of basilar artery
+∞
8.3
8
*
4360A
ICD-9 Finland
Acute but ill-defined cerebrovascular disease[MORBUS CEREBROVASCULARIS ACUTUS NON DEFINITUS]
+∞
8.3
8
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.6
8.3
223
1464
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
2.0
8.3
105
543
11
HP
Coronary artery bypass surgery
2.3
8.3
75
336
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
3.4
8.1
38
115
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
2.2
8.0
79
371
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.4
7.9
64
272
XF600
NOMESCO Finland
Bloodpressure measurement
2.0
7.9
100
519
A46
ICD-10 Finland
Erysipelas
1.6
7.8
240
1625
RD211
NOMESCO Finland
NA
2.3
7.7
66
288
A10AE04
ATC
insulin glargine; parenteral
1.7
7.7
145
862
D64.9
ICD-10 Finland
Anaemia, unspecified
1.6
7.7
205
1344
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.2
7.7
74
343
C10AA03
ATC
pravastatin; oral
1.8
7.6
130
749
N88
ICPC
Epilepsy
11.9
7.6
13
11
RS221
NOMESCO Finland
NA
4.0
7.6
28
70
SPAT1216
SPAT
Assessment of functional ability
1.5
7.6
272
1913
AA9CW
NOMESCO Finland
NA
80.3
7.4
8
*
RT120
NOMESCO Finland
NA
80.3
7.4
8
*
I69.2
ICD-10 Finland
Sequelae of other nontraumatic intracranial haemorrhage
80.3
7.4
8
*
I62.9
ICD-10 Finland
Intracranial haemorrhage (nontraumatic), unspecified
80.3
7.4
8
*
SPAT1229
SPAT
Assessment of need for aid
1.7
7.3
137
814
PA2KT
NOMESCO Finland
Endovascular closure of brain aneurysm
+∞
7.3
7
*
43300
ICD-8 Finland
Cerebral thrombosis, Wtih hypertension (benign)
+∞
7.3
7
*
I61.4
ICD-10 Finland
Intracerebral haemorrhage in cerebellum
+∞
7.3
7
*
AAL00
NOMESCO Finland
Endovascular occlusion of intracranial aneurysm
+∞
7.3
7
*
4300A
ICD-9 Finland
Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOID. POST ANEURYSMA SACCULARE]
+∞
7.3
7
*
C02EA02
ATC
NA
1.8
7.3
115
647
M10.9
ICD-10 Finland
Gout, unspecified
1.8
7.2
124
718
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
7.2
437
3399
R04.0
ICD-10 Finland
Epistaxis
1.7
7.2
135
804
PA7CC
NOMESCO Finland
Very extensive angiography of arteries of neck and brain
30.1
7.1
9
*
PA6AM
NOMESCO Finland
Simple MRI examination of neck vasculature with 3 Tesla magnet
30.1
7.1
9
*
M04AA01
ATC
allopurinol; systemic
1.5
7.1
269
1914
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
8.8
7.0
14
16
I42.0
ICD-10 Finland
Dilated cardiomyopathy
2.3
7.0
62
277
SPAT1252
SPAT
Overall medication plan or its review
1.8
7.0
125
730
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
2.1
7.0
79
393
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.6
7.0
186
1219
N02AX02
ATC
tramadol; systemic, rectal
1.3
7.0
622
5134
B01AE07
ATC
dabigatran etexilate; oral
2.1
7.0
76
371
SPAT1251
SPAT
Organisation of medication
2.1
7.0
78
385
XPX08
NOMESCO Finland
Intraoperative flow measurement
3.8
7.0
27
71
N30.0
ICD-10 Finland
Acute cystitis
1.6
6.9
184
1205
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
2.4
6.9
55
233
I42.9
ICD-10 Finland
Cardiomyopathy, unspecified
3.1
6.9
35
114
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
2.5
6.9
49
196
N03AB02
ATC
phenytoin; systemic
4.6
6.9
22
48
C09AA04
ATC
perindopril; oral
1.9
6.9
102
561
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
1.9
6.8
102
565
XCK00
NOMESCO Finland
Perimetry
1.8
6.8
109
615
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.7
6.8
150
935
C08DB01
ATC
diltiazem; oral
1.7
6.8
135
816
Z95.5
ICD-10 Finland
Presence of coronary angioplasty implant and graft
2.0
6.8
81
410
W19
ICD-10 Finland
Unspecified fall
1.7
6.8
143
880
N06AX11
ATC
mirtazapine; oral
1.4
6.7
397
3065
C03AA03
ATC
hydrochlorothiazide; oral
1.6
6.7
174
1131
I50.1
ICD-10 Finland
Left ventricular failure
1.7
6.7
124
732
A02BC02
ATC
pantoprazole; systemic
1.3
6.7
916
8022
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
6.7
227
1574
RL130
NOMESCO Finland
NA
22.6
6.7
9
*
R4190
NOMESCO Finland
Nutritional therapy
2.9
6.6
38
132
127
Kela drug reimbursment
Transplant complication
4.4
6.5
22
51
XF620
NOMESCO Finland
Examination of circulation with color method
10.0
6.5
12
12
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
10.0
6.5
12
12
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
6.5
210
1441
3A064
NOMESCO Finland
NA
6.9
6.5
15
22
D21
ICPC
Swallowing problem
3.7
6.5
26
71
Z71.8
ICD-10 Finland
Other specified counselling
1.5
6.4
253
1811
C08CA02
ATC
felodipine; oral
1.6
6.4
184
1229
T90
ICPC
Diabetes non-insulin dependent
1.4
6.4
349
2657
G45.3
ICD-10 Finland
Amaurosis fugax
3.0
6.3
33
110
C08CA05
ATC
nifedipine; systemic
1.7
6.3
131
805
RT132
NOMESCO Finland
NA
+∞
6.2
6
*
PA2LT
NOMESCO Finland
Endovascular closure of extensive brain aneurysm
+∞
6.2
6
*
RT152
NOMESCO Finland
NA
+∞
6.2
6
*
I60.3
ICD-10 Finland
Subarachnoid haemorrhage from posterior communicating artery
+∞
6.2
6
*
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.3
6.2
54
240
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.0
6.2
73
370
FFC22
NOMESCO Finland
Percutaneous transluminal closure of ostium secundum type ASD
26.7
6.2
8
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.4
6.2
418
3297
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.6
6.2
142
894
R5599
NOMESCO Finland
Other rehabilitation service
2.6
6.2
42
166
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.1
6.1
68
337
R06.0
ICD-10 Finland
Dyspnoea
1.4
6.1
376
2918
K92
ICPC
Atherosclerosis/periph vascular dis
3.4
6.1
27
80
C10AA07
ATC
rosuvastatin; oral
1.4
6.1
310
2327
N05CF01
ATC
zopiclone; oral
1.3
6.1
519
4238
C01BA01
ATC
quinidine; oral
3.3
6.1
28
86
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.7
6.1
118
709
PD4CM
NOMESCO Finland
Extensive MRI examination of abdominal aorta and vasculature of lower extremities with 3 Tesla magnet
8.6
6.0
12
14
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.5
6.0
226
1600

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3018677) aPTT in Platelet poor plasma by Coagulation assay
643
1956
4.49
192.27
2.8
2.0
s
30.0
30.2
0.31
621
1882
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
830
3982
2.95
110.83
2.7
2.0
u/l
187.9
268.2
1.47
804
3652
(3036489) Thrombin time
175
323
5.87
91.57
2.2
2.1
s
22.0
21.8
0.13
159
289
(3032080) INR in Blood by Coagulation assay
1009
6283
2.32
67.88
16.7
11.5
inr
1.6
1.4
5.29
273
1678
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
199
563
3.83
61.01
3.5
2.5
u/ml
0.4
0.3
1.50
128
315
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
118
269
4.61
48.08
2.4
2.2
%
90.7
84.5
1.96
112
257
(3033658) Prothrombin time (PT) actual/Normal
578
3217
2.15
47.03
5.0
3.9
%
76.6
82.7
6.19
570
3119
(3051593) INR in Capillary blood by Coagulation assay
46
55
8.54
35.64
4.1
23.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
415
2283
2.05
33.19
44.7
30.1
inr
1.9
1.5
4.00
40
330
(3027801) Oxygen [Partial pressure] in Arterial blood
350
1818
2.14
32.56
7.5
6.3
kpa
12.0
11.6
0.61
323
1709
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
350
1819
2.14
32.51
7.5
6.3
kpa
5.0
5.1
1.21
325
1709
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
490
2922
1.92
30.76
6.0
4.1
ng/l
585.1
766.3
0.19
453
2550
(3003396) Base excess in Arterial blood by calculation
343
1821
2.08
29.91
7.5
6.3
mmol/l
1.2
1.2
0.04
272
1369
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
53
93
5.83
29.00
1.2
1.2
u/ml
2.9
3.2
0.22
29
40
(3016502) Oxygen saturation in Arterial blood
309
1629
2.07
27.27
7.9
6.6
%
95.3
95.2
0.10
290
1555
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
100
312
3.33
26.14
2.6
2.4
g/l
3.6
3.6
0.08
95
291
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
51
96
5.43
25.92
1.2
1.2
u/ml
9.5
2.0
0.47
20
27
(3012095) Magnesium [Moles/volume] in Serum or Plasma
383
2251
1.88
24.45
3.7
2.9
mmol/l
0.8
0.8
0.99
357
2054
(4268621)
40
63
6.46
24.37
2.1
2.2
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
181
812
2.36
23.69
9.0
8.1
mmol/l
24.8
24.4
0.69
169
733
(3002173) Hemoglobin [Mass/volume] in Arterial blood
272
1468
2.00
22.21
8.7
7.1
g/l
118.5
119.5
0.35
260
1405
(3023368) Bacteria identified in Blood by Culture
648
4532
1.66
22.14
4.8
4.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
179
825
2.29
21.97
8.8
8.6
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
329
1903
1.88
21.85
8.1
6.2
mmol/l
104.4
104.2
0.17
322
1850
(4306422)
47
96
4.99
21.82
1.1
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
320
1844
1.89
21.47
2.0
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
320
1851
1.88
21.20
2.0
1.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
239
1265
2.02
20.54
9.3
7.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
279
1568
1.91
20.12
3.7
3.2
ng/l
370.0
281.1
1.23
260
1431
(3013826) Glucose [Moles/volume] in Serum or Plasma
1033
8219
1.57
19.88
6.8
4.7
mmol/l
7.0
6.9
0.43
986
7709
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
45
99
4.63
19.16
1.1
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
264
1490
1.90
18.73
2.5
2.5
ug/l
6.9
6.4
0.17
226
1267
(3044640) Blood type and Crossmatch panel - Blood
605
4308
1.60
18.48
2.7
2.6
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
118
493
2.48
18.02
2.2
2.3
ug/l
666.3
677.0
0.01
113
464
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
805
6144
1.54
18.00
4.3
4.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
486
3301
1.64
17.93
2.6
2.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
319
1949
1.77
17.40
6.0
5.3
mmol/l
1.1
1.0
0.37
299
1782
(3020779) Urea [Moles/volume] in Serum or Plasma
246
1391
1.88
17.28
8.1
6.3
mmol/l
11.6
12.1
0.42
233
1304
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
404
2682
1.64
16.10
2.1
1.9
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
235
1339
1.86
16.07
8.1
6.1
mmol/l
1.3
1.4
1.01
224
1280
(3052851) Hemolysis interference index of Serum or Plasma
99
411
2.49
15.34
4.5
3.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
263
1593
1.76
14.63
2.0
1.7
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
370
2473
1.62
14.16
2.8
2.5
umol/l
10.3
12.0
5.04
341
2253
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
139
693
2.08
13.96
4.6
3.2
mmol/l
24.2
24.0
0.29
129
612
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
330
2176
1.63
13.27
2.9
2.5
%
18.2
22.1
7.01
273
1805
(3019060) Gas panel - Arterial blood
194
1109
1.83
13.06
4.7
4.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
344
2300
1.61
13.05
2.9
2.5
g/l
2.2
2.2
0.01
319
2096
(36304419) Bacteria [Presence] in Urine
527
3910
1.48
12.35
3.8
3.3
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
99
465
2.19
11.60
3.3
3.1
nmol/l
0.9
0.8
0.30
78
356
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
15
18
8.38
11.48
1.1
1.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
543
4100
1.46
11.48
3.8
3.3
e6/l
0.5
0.5
0.22
427
3188
(1761868) Lipid panel - Serum or Plasma
220
3398
0.60
11.37
3.2
3.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
32
82
3.95
11.28
5.0
3.6
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
239
1510
1.67
11.28
4.3
3.4
kpa
5.8
5.8
0.19
232
1455
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
15
19
7.94
11.00
1.0
1.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
237
1504
1.66
10.98
4.2
3.4
mmol/l
1.7
2.0
0.47
197
1174
(3009466) Valproate [Moles/volume] in Serum or Plasma
42
132
3.23
10.96
3.7
4.0
umol/l
333.0
341.1
0.14
37
119
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
530
4032
1.44
10.62
2.5
2.2
mg/l
3.1
3.1
0.03
460
3357
(3034426) Prothrombin time (PT)
15
20
7.54
10.55
1.3
1.4
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
19
34
5.63
10.21
1.2
1.1
ratio
1.0
1.1
—
6
5
(3026008) Bacteria identified in Urine by Culture
586
4588
1.40
9.84
3.9
3.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
332
2341
1.51
9.71
3.4
3.1
e6/l
2.2
1.7
0.44
178
1354
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
799
6598
1.37
9.65
7.8
5.8
mmol/l
1.2
1.2
3.52
738
5863
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
348
2483
1.49
9.60
3.2
2.9
e6/l
1.2
1.2
0.20
196
1489
(3002582) Erythrocytes [#/volume] in Urine
577
4523
1.40
9.57
3.8
3.4
e6/l
317.9
85.0
0.61
452
3582
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
717
5825
1.37
9.57
5.2
4.2
ng/l
58.1
96.4
0.62
599
4528
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
871
7297
1.36
9.56
8.6
6.7
mmol/l
1.2
1.2
2.89
754
6059
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
167
1001
1.73
9.55
2.1
1.7
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
709
5755
1.37
9.49
6.3
5.6
%
0.6
0.6
1.06
688
5294
(3024561) Albumin [Mass/volume] in Serum or Plasma
764
6284
1.36
9.38
5.5
4.6
g/l
33.2
34.4
6.72
712
5748
(3008152) Bicarbonate [Moles/volume] in Arterial blood
169
1030
1.70
9.10
7.3
6.1
mmol/l
24.5
24.4
0.14
153
951
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
24
59
4.10
8.97
2.2
2.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
768
6375
1.35
8.68
6.1
5.4
e9/l
1.7
1.9
2.90
667
5482
(3018010) Neutrophils/100 leukocytes in Blood
721
5929
1.35
8.67
6.4
5.6
%
61.2
58.9
6.26
699
5462
(42870588) Differential panel, method unspecified - Blood
558
4421
1.37
8.48
5.7
5.4
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
720
5935
1.35
8.46
6.7
5.9
%
9.1
9.0
0.27
696
5475
(3006504) Eosinophils/100 leukocytes in Blood
717
5913
1.34
8.38
6.4
5.6
%
2.8
2.9
0.49
695
5435
(3001604) Monocytes [#/volume] in Blood
750
6228
1.34
8.36
6.0
5.3
e9/l
0.7
0.6
2.44
641
5237
(3018572) Chloride [Moles/volume] in Blood
75
363
2.11
8.23
5.7
6.0
mmol/l
103.6
105.2
1.39
65
321
(3039000) Anion gap in Blood
75
363
2.11
8.23
5.7
6.0
mmol/l
11.2
11.3
0.07
65
321
(3006315) Basophils [#/volume] in Blood
752
6260
1.34
8.20
6.0
5.3
e9/l
0.0
0.0
0.65
645
5282
(3018418) pH of Serum or Plasma
541
4286
1.37
8.17
4.5
3.9
ph
7.4
7.4
0.12
96
825
(3024354) Oxygen [Partial pressure] in Venous blood
191
1239
1.60
8.06
3.6
2.9
kpa
5.1
4.4
1.64
185
1192
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
140
843
1.71
7.89
1.5
1.8
g/l
1.6
1.5
0.32
124
716
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
652
5341
1.34
7.84
4.0
3.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
635
5188
1.34
7.76
3.9
3.3
ng/l
2695.7
2017.1
1.59
561
4517
(3031040) Bacteria [#/volume] in Urine by Automated count
1041
9131
1.31
7.63
5.8
4.9
e6/l
4387.4
2490.1
0.18
11
172
(3002030) Lymphocytes/100 leukocytes in Blood
723
6037
1.32
7.54
6.6
5.8
%
23.2
25.5
7.87
700
5525
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
119
699
1.75
7.34
4.8
4.6
%
1.6
1.6
0.13
108
653
(3013115) Eosinophils [#/volume] in Blood
765
6455
1.31
7.34
6.3
5.5
e9/l
0.2
0.2
0.02
672
5542
(3051611) Lipemic interference index of Serum or Plasma
39
151
2.61
7.12
4.9
3.5
—
—
—
0
0
(3026782) Osmolality of Urine
398
3067
1.38
7.00
3.0
2.9
mosm/kgh2o
538.2
559.4
1.34
355
2605
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
262
1878
1.46
6.94
3.2
4.0
u/l
250.5
253.1
0.09
244
1753
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
67
333
2.05
6.90
1.1
1.3
—
8.1
—
0
5
(3024928) Oxygen saturation in Venous blood
63
308
2.08
6.78
2.5
2.5
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
57
270
2.14
6.66
1.8
2.8
umol/l
26.9
34.5
2.26
46
216
(3007930) Methemoglobin/Hemoglobin.total in Blood
115
689
1.71
6.63
4.9
4.6
%
0.9
0.9
0.09
105
642
(3018095) Leukocytes [#/volume] in Urine
615
5099
1.31
6.52
4.4
3.9
e6/l
90.8
133.2
1.04
463
3807
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
142
904
1.62
6.50
1.5
1.5
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
16
38
4.23
6.28
17.1
24.8
ug/l
89.5
120.6
—
10
30
(3042936) Bacteria identified in Isolate by Culture
276
2042
1.41
6.13
2.1
2.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
174
1179
1.52
6.08
2.6
2.4
u/l
37.5
36.6
0.07
144
988
(3047181) Lactate [Moles/volume] in Blood
87
502
1.77
5.76
6.0
5.5
mmol/l
1.3
1.4
0.92
77
435
(3027945) Reticulocytes/100 erythrocytes in Blood
272
2038
1.39
5.60
2.2
2.4
%
1.9
1.8
1.36
241
1771
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
726
6253
1.26
5.45
2.3
2.1
pmol/l
90.4
91.8
0.34
417
3301
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
19
57
3.35
5.43
7.6
7.7
%
74.1
73.4
0.04
19
46
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
160
1094
1.50
5.37
1.7
1.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
207
1490
1.44
5.35
2.0
2.5
umol/l
8.9
10.8
0.65
186
1301
(3045716) Anion gap in Serum or Plasma
21
68
3.11
5.33
2.5
1.6
mmol/l
10.2
9.1
0.44
13
57
(3013650) Neutrophils [#/volume] in Blood by Automated count
836
7334
1.25
5.31
8.7
8.5
e9/l
4.6
4.4
1.56
720
6301
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
815
7130
1.25
5.30
3.5
3.1
u/l
61.6
58.1
0.36
778
6387
(3037467) Urinalysis macro (dipstick) panel - Urine
1029
9248
1.25
5.24
5.6
4.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
458
3756
1.29
5.07
3.1
3.0
u/l
48.1
34.2
0.78
427
3535
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
183
1301
1.45
5.06
1.7
2.1
g/l
0.2
0.2
0.12
165
1196
(3000850) Epithelial cells [#/volume] in Urine
399
3225
1.30
4.92
2.9
2.7
e6/l
4.5
4.4
0.08
371
2851
(40768804) Tissue Pathology biopsy report
419
5066
0.78
4.90
2.3
2.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
334
2646
1.32
4.76
2.1
1.6
mg/l
1.6
1.6
0.05
261
2071
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
18
57
3.18
4.76
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
18
57
3.18
4.76
1.1
1.0
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
61
337
1.84
4.72
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
61
337
1.84
4.72
1.4
1.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
618
5310
1.24
4.54
3.4
2.8
ug/l
137.0
167.0
3.17
566
4732
(3021960) Folate [Moles/volume] in Serum or Plasma
454
3766
1.27
4.52
1.7
1.6
nmol/l
18.6
19.6
0.82
406
3156
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
14
40
3.52
4.32
1.1
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
24
95
2.54
4.29
1.7
1.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
808
7173
1.22
4.29
6.0
6.1
umol/l
13.4
12.7
0.69
779
6767
(3011985) Renin [Units/volume] in Plasma
30
132
2.29
4.29
1.3
1.3
mu/l
133.6
59.5
0.59
22
112
(3023520) Reticulocytes [#/volume] in Blood
204
1537
1.37
4.06
2.4
2.6
e9/l
72.0
67.8
0.77
148
1201
(3006922) Hepatitis E virus Ab [Presence] in Serum
17
61
2.80
3.68
1.1
1.0
—
—
—
0
0
(3013512) EKG study
370
4397
0.80
3.56
5.5
4.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
596
6744
0.83
3.53
4.7
5.6
ug/l
3.0
4.7
1.53
527
5931
(44790048)
31
152
2.05
3.46
1.6
1.5
—
—
—
0
0
(44790047)
31
152
2.05
3.46
1.6
1.5
—
—
—
0
0
(44790049)
31
152
2.05
3.46
1.6
1.5
—
—
—
0
0
(44806118)
31
152
2.05
3.46
1.6
1.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
508
4381
1.22
3.45
3.1
3.1
mmol/l
7.0
7.4
0.95
428
3585
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
7
10
7.01
3.36
1.0
1.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
361
3018
1.24
3.28
4.4
3.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
52
309
1.70
3.24
1.5
1.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1088
11623
0.84
3.19
25.3
16.5
ml/min/173m2
70.5
71.2
0.40
953
9597
(3014271) Vancomycin [Susceptibility]
21
91
2.32
3.17
2.9
3.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
500
4344
1.20
3.10
3.2
3.2
mg/l
557.7
256.0
0.67
354
2839
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
14
50
2.81
3.08
2.3
1.2
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
47
276
1.72
3.07
1.4
1.3
mmol/l
60.0
63.2
0.25
36
221
(3011648) Oxygen content in Venous blood
22
99
2.23
3.05
1.6
1.7
%
10.4
10.6
0.07
22
99
(40758558) Short blood count panel - Blood
369
3116
1.23
3.05
7.2
6.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
59
369
1.62
3.05
1.3
1.4
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
10
29
3.46
3.04
1.2
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
10
29
3.46
3.04
1.2
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
10
29
3.46
3.04
1.2
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
10
29
3.46
3.04
1.2
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
38
211
1.82
3.00
1.3
1.4
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
25
122
2.06
2.86
1.3
1.3
e6/l
9149.9
54219.0
1.12
19
86
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
65
424
1.55
2.84
1.8
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
524
4612
1.19
2.78
3.6
3.9
mg/mmol
16.8
8.8
2.57
359
2991
(3002621) Streptococcal DNAse B [Units/volume] in Serum
5
6
8.34
2.75
1.4
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
39
225
1.75
2.74
1.3
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
17
366
0.46
2.73
3.9
3.5
mg/l
34.9
30.9
—
10
242
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1151
12160
0.86
2.63
5.4
5.1
mmol/l
6.3
6.1
5.08
1065
10688
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
21
100
2.11
2.58
1.6
1.3
—
—
—
0
0
(4198724)
6
11
5.46
2.54
1.2
1.0
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
44
270
1.64
2.50
1.1
1.3
—
56.7
—
0
6
(3035637) Corticotropin [Mass/volume] in Plasma
24
122
1.98
2.50
1.4
1.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
19
89
2.14
2.44
2.1
1.3
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
19
89
2.14
2.44
1.4
1.5
u/field
3.2
2.2
0.18
11
66
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
483
5423
0.85
2.42
4.2
4.8
%
21.2
22.0
0.49
206
2928
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
21
103
2.05
2.41
1.6
1.3
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
22
110
2.01
2.40
1.5
1.3
%
33.5
24.4
0.55
15
69
(3003434) Protein [Mass/volume] in Pleural fluid
48
305
1.59
2.39
1.4
1.5
g/l
29.0
30.5
0.29
39
280
(3012441) Differential panel - Pleural fluid
37
220
1.69
2.38
1.5
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
35
205
1.72
2.37
1.5
1.4
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
11
40
2.76
2.37
1.4
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
14
58
2.42
2.36
1.1
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
18
85
2.13
2.28
2.7
2.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
12
47
2.56
2.26
1.4
1.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
100
744
1.36
2.26
1.1
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
387
3376
1.18
2.24
1.8
1.9
nmol/l
1099.6
1165.0
0.70
310
2474
(3028308) Erythrocytes [#/volume] in Pleural fluid
39
240
1.64
2.22
1.4
1.4
e6/l
53554.8
87955.7
0.47
21
138
(3000475) Leukocytes [#/volume] in Synovial fluid
50
327
1.54
2.22
1.5
1.7
e6/l
12409.0
18716.0
0.87
37
237
(40768806) Pleura Pathology biopsy report
36
217
1.67
2.22
1.5
1.6
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
21
107
1.97
2.20
1.2
1.2
mmol/l
31.1
35.3
0.40
14
93
(3010813) Leukocytes [#/volume] in Blood
1306
13600
0.86
2.19
38.1
25.4
e9/l
7.3
7.0
6.63
1251
13034
(3000963) Hemoglobin [Mass/volume] in Blood
1306
13598
0.86
2.18
38.4
25.5
g/l
128.6
132.5
14.71
1273
13250
(40757373) Influenza virus identified in Isolate
11
42
2.63
2.18
1.3
1.5
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
1306
13595
0.86
2.16
38.1
25.3
e12/l
4.3
4.4
8.46
1247
13031
(3035941) MCH [Entitic mass]
1306
13594
0.87
2.15
37.9
25.2
pg
30.4
30.5
0.90
1275
13245
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
6
14
4.29
2.15
8.2
20.0
mmol/l
5.0
5.9
—
6
14
(3024731) MCV [Entitic volume]
1306
13593
0.87
2.15
38.0
25.3
fl
92.0
91.9
0.38
1275
13243
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
51
338
1.52
2.14
1.4
1.6
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1306
13592
0.87
2.14
38.1
25.3
e9/l
236.8
236.2
0.12
1261
13088
(3024980) IgG subclass 4 [Mass/volume] in Serum
26
145
1.80
2.10
1.7
1.4
g/l
0.9
0.8
0.12
20
106
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
39
245
1.60
2.07
1.3
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
30
492
0.60
2.06
2.1
1.8
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
165
1334
1.26
2.06
1.3
1.3
titre
306.3
469.5
1.79
41
292
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
37
230
1.62
2.05
4.3
5.3
iu/ml
125.7
427.4
—
7
35
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
25
139
1.81
2.04
1.2
1.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
336
3829
0.85
1.99
3.0
3.3
ug/l
0.8
0.8
0.04
223
2761
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
26
148
1.77
1.98
1.2
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
41
265
1.56
1.95
1.3
1.2
u/ml
45.5
3.8
—
8
22
(3044009) aPTT.lupus sensitive (LA screen)
5
11
4.55
1.94
1.4
1.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
132
1047
1.28
1.94
2.2
2.1
nmol/l
389.9
377.6
0.28
118
939
(3023199) Leukocytes [#/volume] in Pleural fluid
41
266
1.55
1.92
1.5
1.4
e6/l
3650.1
1559.2
0.47
24
190
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
140
1120
1.27
1.92
4.6
3.6
ng/l
118.4
97.8
1.61
124
941
(1001926) Buprenorphine [Presence] in Urine by Screen method
15
71
2.12
1.92
1.3
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
34
211
1.62
1.91
1.3
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1004
9460
1.13
1.90
4.7
4.1
mm/h
16.4
14.9
2.06
967
8528
(3036782) Glucose [Moles/volume] in Pleural fluid
33
204
1.63
1.89
1.3
1.4
mmol/l
7.6
6.3
0.90
28
192
(3005719) IgG [Mass/volume] in Serum or Plasma
112
873
1.30
1.89
2.6
2.8
g/l
10.7
10.9
0.15
103
780
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
27
158
1.72
1.88
1.4
1.5
%
62.0
66.3
0.25
17
104
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
41
268
1.54
1.87
1.3
1.2
u/ml
4.3
8.5
—
10
38
(3008295) Osmolality of Serum or Plasma
24
136
1.77
1.87
1.3
1.4
mosm/kgh2o
279.3
274.9
0.20
19
92
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
27
159
1.71
1.85
1.2
1.3
u/l
11.5
14.8
0.50
22
149
(21494755) Public health laboratory ask at order entry panel
24
403
0.59
1.83
1.2
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
23
130
1.78
1.81
1.2
1.8
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
12
53
2.27
1.80
1.3
1.7
nmol/l
11.9
16.5
1.34
12
46
(3044290) Cell count panel - Cerebral spinal fluid
30
186
1.62
1.72
1.6
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
118
939
1.27
1.72
1.8
1.5
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
34
218
1.57
1.70
1.7
1.3
e6/l
7.1
48.9
0.87
28
171
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
34
218
1.57
1.70
1.7
1.4
e6/l
1431.2
731.6
0.31
28
177
(3024891) Influenza virus A+B Ag [Presence] in Specimen
44
299
1.48
1.70
1.2
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
17
89
1.92
1.69
1.4
1.4
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
29
179
1.63
1.69
1.9
2.5
—
2027.9
—
0
19
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
16
82
1.96
1.69
1.0
1.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
121
969
1.26
1.68
5.0
3.6
mmol/l
1.1
2.0
1.84
86
717
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
68
504
1.36
1.64
1.4
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
51
360
1.43
1.63
1.4
1.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1268
13140
0.89
1.63
13.2
10.9
u/l
26.8
24.6
0.70
1236
12446
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
76
575
1.33
1.61
3.2
3.0
pmol/l
4.2
4.4
0.98
66
491
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
5
14
3.57
1.61
1.2
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
123
993
1.25
1.60
1.7
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
146
1758
0.82
1.60
1.4
1.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
16
84
1.91
1.59
1.6
2.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
17
92
1.85
1.55
1.4
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
16
85
1.89
1.54
1.7
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
21
2.86
1.50
1.2
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
11
51
2.16
1.50
1.3
1.2
—
—
—
0
0
(3020891) Body temperature
83
644
1.30
1.50
6.6
4.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
14
72
1.95
1.48
1.4
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
124
1013
1.24
1.47
5.1
3.7
ph
7.4
7.4
1.16
13
123
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
41
284
1.45
1.47
1.4
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
17
94
1.81
1.47
1.4
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
17
94
1.81
1.47
1.4
1.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
92
726
1.28
1.47
2.2
1.8
ug/l
2.1
2.5
0.12
77
636
(40760892) CBC W Ordered Manual Differential panel - Blood
218
2508
0.85
1.46
5.1
4.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
26
163
1.60
1.46
1.0
1.1
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
7
28
2.50
1.45
1.1
1.7
pmol/l
15.6
15.6
—
7
20
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
15
80
1.88
1.44
1.0
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
15
80
1.88
1.44
1.0
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
45
319
1.42
1.44
2.2
2.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
16
3.13
1.43
1.0
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
6
22
2.73
1.43
1.2
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
9
39
2.31
1.43
1.2
1.9
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
9
39
2.31
1.43
1.2
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
76
588
1.30
1.41
2.5
2.7
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
40
2.25
1.40
1.3
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
77
598
1.30
1.40
1.4
1.3
—
—
—
0
0
(3000492) Spirometry study
117
957
1.24
1.39
1.7
1.5
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
125
1030
1.23
1.39
5.1
3.7
kpa
5.1
5.2
0.37
117
940
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
49
356
1.39
1.38
1.7
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
93
1154
0.79
1.37
5.7
4.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
20
323
0.61
1.37
1.6
1.5
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
26
166
1.57
1.37
1.3
2.0
u/field
2.1
2.2
0.04
12
59
(3016018) Differential panel - Cerebral spinal fluid
16
89
1.80
1.37
2.1
1.2
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
17
2.94
1.36
1.2
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
12
220
0.54
1.32
1.9
1.8
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
82
1025
0.79
1.30
2.1
2.2
nmol/l
10.8
12.0
0.44
66
874
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
47
343
1.38
1.30
1.8
1.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
9
44
2.05
1.26
1.3
1.7
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
25
162
1.55
1.25
3.2
2.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
33
229
1.45
1.21
1.2
1.4
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
8
37
2.16
1.21
1.1
1.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
163
1399
1.18
1.21
1.7
2.6
g/l
65.4
66.0
0.43
146
1253
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
30
206
1.46
1.17
1.4
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
16
94
1.71
1.17
1.4
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
340
3083
1.12
1.17
1.3
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29
198
1.47
1.16
1.3
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
32
223
1.44
1.16
1.3
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
29
199
1.46
1.14
2.4
2.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
76
608
1.26
1.14
6.3
4.2
mmol/l
24.6
25.0
0.62
71
559
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
460
4954
0.90
1.12
5.3
4.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
11
58
1.90
1.11
1.0
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
587
5497
1.10
1.09
11.5
10.5
e9/l
0.0
0.0
0.17
466
4440
(3014148) Varicella zoster virus Ab [Titer] in Serum
12
66
1.82
1.08
1.1
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
308
3382
0.89
1.07
4.6
3.7
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
32
227
1.42
1.07
1.4
1.6
iu/l
2.8
5.1
—
6
69
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
59
1.87
1.07
1.0
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
960
9196
1.09
1.07
5.2
4.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
69
856
0.80
1.07
1.4
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
23
153
1.51
1.06
1.7
1.4
u/ml
117.6
138.2
—
5
35
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
309
3389
0.89
1.06
1.7
1.8
pmol/l
31907043.6
11012990.1
0.29
257
2706
(1761482) Bacteria [#/volume] in Urine by Culture
37
498
0.74
1.05
5.0
4.5
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
7
33
2.12
1.05
1.0
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
33
2.12
1.05
1.1
1.4
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
7
33
2.12
1.05
1.0
1.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
20
129
1.55
1.05
1.3
1.2
—
61.2
—
0
7
(40768800) Prostate Pathology biopsy report
33
451
0.73
1.04
1.1
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
404
3726
1.11
1.03
3.3
2.9
umol/l
1279.2
8317.8
6.76
335
3125
(40761535) Cells panel - Urine sediment
147
1271
1.17
1.02
4.3
3.6
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
26
179
1.46
1.02
2.9
3.7
—
—
—
0
0
(4211845)
11
60
1.84
1.02
2.4
3.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
7
35
2.00
1.00
1.4
1.5
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
94
784
1.21
0.99
4.4
3.9
%
51.6
47.3
1.00
94
773
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
31
223
1.40
0.98
1.1
1.1
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
14
84
1.67
0.97
1.0
1.0
mg/l
324.9
286.5
1.16
14
72
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
30
0.00
0.97
0.0
2.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
135
1166
1.17
0.96
1.7
1.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
460
4284
1.10
0.96
2.6
2.4
u/l
63.0
57.4
1.52
436
3908
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
0
31
0.00
0.96
0.0
1.3
—
26.7
—
0
7
(3022145) Colonoscopy Study observation
117
1360
0.85
0.95
1.4
1.3
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
71
578
1.24
0.95
2.3
3.4
mg/l
54.9
74.3
0.73
60
469
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
71
578
1.24
0.95
2.3
3.5
mg/l
38.3
76.3
0.99
61
472
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1186
12192
0.92
0.94
6.1
5.2
mmol/l
2.1
2.6
74.75
1125
10811
(3028026) IgM [Mass/volume] in Serum or Plasma
84
698
1.21
0.93
1.9
1.9
g/l
1.2
1.7
0.76
78
618
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
69
562
1.24
0.92
2.3
3.4
ratio
3.4
2.0
—
9
42
(3006462) Nitrate [Presence] in Urine
10
56
1.79
0.87
2.2
3.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
14
87
1.61
0.87
1.0
1.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
8
43
1.86
0.87
1.0
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
6
30
2.00
0.87
1.7
1.3
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1018
9828
1.08
0.86
35.9
22.9
g/l
330.0
331.4
4.28
995
9691
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
56
450
1.25
0.86
1.8
2.5
g/l
0.0
0.0
1.96
51
403
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
607
5749
1.08
0.85
2.7
2.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
19
128
1.49
0.85
1.4
1.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
22
153
1.44
0.85
1.0
1.2
u/ml
217.8
299.1
0.83
11
83
(3009261) Glucose [Presence] in Urine by Test strip
679
6462
1.08
0.84
4.5
3.9
estimate
0.0
0.0
0.80
140
1171
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
111
960
1.16
0.81
1.6
1.7
%
1.8
1.6
2.04
91
785
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
12
188
0.64
0.80
1.5
2.2
u/ml
36.5
1641.0
0.59
12
181
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
17
114
1.49
0.79
1.1
1.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
25
0.00
0.79
0.0
1.3
—
105.1
—
0
20
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1288
12569
1.08
0.78
26.8
17.1
mg/l
27.9
28.7
0.36
1176
10287
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
125
1096
1.15
0.77
3.7
3.1
ml/min/173m2
52.3
58.4
1.13
61
487
(3005570) Glucose [Moles/volume] in Urine
23
165
1.40
0.77
1.5
1.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
32
416
0.76
0.77
1.2
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
18
123
1.47
0.77
1.2
1.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
6
34
1.77
0.76
2.5
2.2
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
0
28
0.00
0.76
0.0
1.1
—
2.4
—
0
11
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
52
422
1.24
0.75
1.9
2.4
g/l
0.0
0.0
0.00
47
378
(3011412) CD3 cells [#/volume] in Blood
15
99
1.52
0.75
1.9
2.2
e9/l
1.0
1.0
—
10
57
(3004616) Nuclear Ab [Presence] in Serum
21
149
1.41
0.75
1.1
1.2
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
5
24
2.08
0.74
1.0
1.5
ug/l
0.3
0.4
—
5
13
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
6
109
0.55
0.72
1.0
1.0
—
1.6
—
0
31
(3021788) Differential panel - Synovial fluid
32
246
1.30
0.71
1.5
1.6
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
11
68
1.62
0.71
2.1
2.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
668
6389
1.07
0.71
4.5
3.9
estimate
0.0
0.0
0.00
141
1205
(21494814) CD8 cells/100 lymphocytes in Specimen
7
40
1.75
0.71
2.3
2.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
161
1446
1.12
0.70
1.5
1.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
68
573
1.19
0.70
2.0
2.6
g/l
3.3
3.2
0.57
58
440
(3034770) Mitochondria Ab [Titer] in Serum
36
283
1.28
0.69
1.1
1.2
—
1136.3
—
0
8
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
85
1.53
0.68
1.1
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
9
59
1.53
0.68
1.0
1.1
mg/l
60.4
43.4
—
9
50
(3033705) Calcium.ionized [Moles/volume] in Venous blood
30
231
1.30
0.67
3.1
2.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
31
240
1.30
0.67
2.6
3.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
91
0.55
0.67
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
92
0.54
0.67
1.2
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
5
28
1.79
0.66
1.4
1.7
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
5
28
1.79
0.66
1.4
3.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
22
162
1.36
0.66
1.0
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
5
29
1.72
0.64
1.2
1.6
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
18
129
1.40
0.63
1.1
1.1
u/l
45.4
54.4
0.78
11
86
(3023103) Potassium [Moles/volume] in Serum or Plasma
1305
13284
0.94
0.63
33.2
20.8
mmol/l
4.0
4.0
0.14
1269
12834
(3045414) Leukocytes [Presence] in Urine
66
562
1.18
0.62
2.0
2.0
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
12
79
1.52
0.62
1.4
1.5
u/l
1.4
9.6
—
5
39
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
19
138
1.38
0.62
1.4
1.2
nmol/l
—
0.1
—
0
5
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
19
138
1.38
0.62
1.4
1.2
nmol/l
0.6
0.7
0.26
19
128
(44816559) Phosphatidylethanol [Mass/volume] in Blood
22
164
1.34
0.62
1.1
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
26
199
1.31
0.62
1.3
1.5
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
5
30
1.67
0.61
1.0
1.2
pmol/l
—
8.0
—
0
5
(40768797) Stomach Pathology biopsy report
156
1715
0.90
0.61
1.3
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
153
1682
0.90
0.60
3.2
4.0
ug/l
16.3
28.9
0.59
126
1407
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
22
165
1.34
0.60
1.0
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
14
97
1.45
0.58
1.3
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
14
97
1.45
0.58
2.8
2.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
26
201
1.30
0.58
1.2
1.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
69
594
1.17
0.58
2.0
2.5
g/l
10.0
10.4
0.36
60
490
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
2.4
—
2.9
—
0
12
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
18
242
0.74
0.58
2.4
2.8
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
8
53
1.51
0.58
2.0
4.9
%
13.3
13.3
—
8
53
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
32
255
1.26
0.58
1.3
1.7
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
35
1.71
0.57
1.0
1.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1305
13268
0.94
0.57
33.1
20.6
mmol/l
139.3
139.6
3.22
1267
12842
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
61
521
1.18
0.57
1.8
2.6
g/l
1.0
1.6
0.35
53
430
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
22
167
1.32
0.56
1.4
1.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
535
5121
1.06
0.55
2.4
2.2
nmol/l
76.2
79.1
1.54
477
4370
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
10
65
1.54
0.55
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
10
65
1.54
0.55
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
10
65
1.54
0.55
1.1
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
38
312
1.22
0.54
1.4
1.3
—
—
—
0
0
(4027681)
6
39
1.54
0.53
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
10
66
1.52
0.52
1.1
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
66
1.52
0.52
1.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
10
66
1.52
0.52
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
10
66
1.52
0.52
1.1
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
84
742
1.14
0.52
5.8
3.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
99
0.60
0.52
1.2
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
13
180
0.72
0.51
3.6
4.8
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
9
64
1.41
0.51
1.0
1.2
nmol/l
173.7
137.8
—
9
64
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
72
630
1.15
0.51
2.0
2.5
g/l
3.7
3.9
0.50
56
430
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
305
2875
1.07
0.51
3.1
3.1
mmol/l
2.5
2.5
1.93
262
2488
(3004588) Protein electrophoresis panel - Serum or Plasma
130
1181
1.11
0.51
1.7
2.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
64
733
0.87
0.50
1.1
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
72
631
1.15
0.50
2.0
2.5
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
22
280
0.78
0.50
2.6
4.0
%
0.5
1.6
2.93
14
208
(3005322) IgE [Units/volume] in Serum or Plasma
61
528
1.16
0.50
1.3
1.2
u/ml
428.4
184.8
1.17
55
475
(3028433) Virus identified in Specimen by Culture
6
41
1.46
0.50
1.0
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1008
9839
1.05
0.50
32.7
21.0
%
14.3
14.0
8.13
982
9582
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
72
632
1.14
0.49
2.0
2.5
g/l
7.5
7.5
0.00
56
443
(3022621) pH of Urine by Test strip
105
945
1.12
0.49
2.8
3.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
56
483
1.16
0.48
1.8
2.3
g/l
34.4
37.2
2.82
50
398
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
159
1718
0.92
0.47
5.7
4.6
%
33.4
32.8
0.28
148
1050
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
26
209
1.25
0.46
2.4
2.3
mg/l
37.6
25.3
—
6
44
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
82
0.61
0.45
1.0
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
82
0.61
0.45
1.0
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
82
0.61
0.45
1.0
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
82
0.61
0.45
1.0
1.7
—
—
—
0
0
(3019977) pH of Arterial blood
13
94
1.38
0.45
1.8
3.1
ph
7.4
7.4
—
5
33
(3029937) Albumin [Presence] in Urine by Test strip
342
3586
0.94
0.45
5.6
4.2
estimate
0.0
0.0
0.50
125
1135
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
50
1.40
0.45
1.0
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1162
11813
0.95
0.45
5.3
4.6
mmol/l
3.8
4.4
73.20
1109
10535
(3021601) Nitrite [Presence] in Urine by Test strip
659
6381
1.05
0.44
6.0
5.3
estimate
0.0
0.0
0.50
133
1204
(3025159) Blasts/100 leukocytes in Blood
112
1019
1.10
0.44
4.2
4.1
%
0.0
0.5
0.99
27
295
(3003327) Ova and parasites identified in Stool by Light microscopy
34
284
1.20
0.43
1.5
1.6
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
31
1.61
0.43
5.0
6.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
106
1161
0.91
0.43
1.2
1.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
32
1.56
0.42
1.0
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
114
1042
1.10
0.42
3.9
4.0
%
0.2
0.6
2.84
24
271
(3000093) Morphology [Interpretation] in Blood Narrative
17
131
1.30
0.42
1.0
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
23
185
1.24
0.41
1.7
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1256
12732
0.96
0.41
24.1
16.9
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
15
114
1.32
0.40
1.4
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
18
0.00
0.40
0.0
1.9
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.3
—
66.0
—
0
5
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
14
106
1.32
0.39
2.1
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
9
66
1.36
0.38
1.4
2.0
—
—
—
0
0
(1002224) Polysomnography panel
33
280
1.18
0.37
1.0
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
37
1.35
0.37
1.4
2.8
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
10
72
1.39
0.36
2.1
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
10
72
1.39
0.36
2.1
1.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1051
10317
1.04
0.36
8.3
7.5
u/l
83.5
82.1
0.39
1007
9557
(40768443) Skin Pathology biopsy report
51
576
0.88
0.36
1.3
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
89
811
1.10
0.36
2.5
2.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
15
117
1.28
0.35
1.8
1.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1151
11667
0.96
0.34
7.2
6.5
mmol/mol
42.4
41.1
4.30
1083
10461
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
21
254
0.82
0.34
1.1
1.2
nmol/l
0.9
0.8
0.05
16
203
(4094501)
25
297
0.84
0.34
1.2
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
201
1902
1.06
0.33
1.5
1.5
g/l
2.7
2.8
0.26
112
1068
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
21
253
0.83
0.33
3.9
3.6
%
62.1
59.0
0.47
21
253
(3030905) Polymorphonuclear cells [#/volume] in Blood
20
242
0.82
0.33
3.6
3.2
e9/l
4.5
4.5
0.03
20
242
(40757494) Bilirubin.total [Moles/volume] in Blood
6
87
0.69
0.33
2.7
2.0
—
35.1
—
0
7
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
46
1.30
0.33
1.3
1.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
14
110
1.27
0.31
1.5
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
60
542
1.11
0.30
3.6
3.0
g/l
0.3
0.3
0.25
29
212
(3000570) Elastase.pancreatic [Mass/mass] in Stool
44
390
1.13
0.30
1.3
1.4
ug/g
182.1
274.5
2.25
24
237
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
37
324
1.14
0.30
1.5
1.6
iu/ml
0.4
16.6
—
6
74
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
64
581
1.10
0.30
2.1
3.0
u/ml
135.7
2997.4
0.97
59
490
(3048879) Bone marrow aspiration report
7
55
1.27
0.30
1.1
1.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
55
1.27
0.30
1.1
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
17
139
1.22
0.28
1.4
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
102
1091
0.93
0.28
2.4
2.1
ug/g
212.1
154.0
0.89
80
845
(3015377) Calcium [Moles/volume] in Serum or Plasma
499
4855
1.04
0.27
3.3
3.3
mmol/l
2.3
2.3
0.03
440
4095
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
53
479
1.11
0.27
1.3
1.8
u/l
37.2
39.2
0.28
45
410
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
204
2130
0.95
0.26
1.2
1.2
u/ml
1.8
1.5
0.10
32
508
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
72
0.69
0.26
1.6
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
83
771
1.08
0.25
2.5
2.7
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
9
74
1.22
0.25
1.0
1.1
mmol/l
2.3
2.1
—
9
67
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1154
11659
0.97
0.25
5.2
4.6
mmol/l
1.3
1.4
25.02
1092
10301
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
176
1841
0.95
0.25
11.7
8.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
73
676
1.08
0.24
2.0
2.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
12
96
1.25
0.24
1.7
1.7
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
5
38
1.32
0.23
1.2
1.2
—
59.7
—
0
7
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
10
125
0.80
0.23
1.4
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
17
200
0.85
0.23
1.1
1.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
5
39
1.28
0.23
2.4
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
32
358
0.89
0.23
1.6
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
101
1070
0.94
0.22
1.5
1.5
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
40
1.25
0.22
1.2
1.0
—
—
—
0
0
(3035880) pH of Pleural fluid
15
125
1.20
0.22
1.1
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
19
220
0.86
0.21
2.1
1.7
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
5
42
1.19
0.21
1.2
1.9
nmol/l
12.6
6.0
—
5
35
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
26.5
—
0
10
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
43
1.16
0.21
1.0
1.1
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(4010399)
89
943
0.94
0.20
1.4
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
41
373
1.10
0.20
4.1
3.9
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
37
335
1.11
0.20
1.3
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
48
441
1.09
0.20
2.5
3.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
46
422
1.09
0.20
1.3
1.2
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
29
323
0.90
0.20
1.7
3.2
u/ml
77.1
1629.6
1.11
29
296
(3048929) Epstein Barr virus Ab [Presence] in Serum
24
212
1.13
0.19
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
37
337
1.10
0.18
1.3
1.2
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
10
81
1.23
0.18
2.1
3.8
nmol/l
189.2
106.8
—
10
81
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
29
321
0.90
0.18
1.2
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
66
619
1.07
0.17
2.0
1.8
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
23
204
1.13
0.17
1.1
1.2
—
—
—
0
0
(4024509)
12
142
0.84
0.17
2.2
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
62
1.13
0.17
1.0
1.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
37
339
1.09
0.17
1.3
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
70
0.71
0.16
1.0
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
76
0.79
0.15
1.0
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
6
79
0.76
0.15
2.3
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
80
0.75
0.15
2.0
2.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
9
81
1.11
0.15
1.0
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
17
192
0.88
0.15
1.5
1.4
—
—
—
0
0
(3019225) pH of Specimen
149
1539
0.96
0.14
5.0
4.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
317
3100
1.03
0.14
1.8
1.6
mmol/l
1.3
1.3
0.02
286
2531
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
38
409
0.93
0.14
2.4
2.4
ug/min
201.3
91.6
0.50
24
240
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
44
410
1.07
0.14
1.0
1.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
15
131
1.14
0.14
1.1
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1068
10751
0.98
0.14
31.4
18.6
%
38.1
38.3
0.29
673
6396
(3017732) Neutrophils [#/volume] in Blood
76
796
0.95
0.14
3.6
3.2
e9/l
4.5
4.2
0.31
56
564
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
10
84
1.19
0.13
1.1
1.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
97
0.82
0.13
1.0
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
99
0.81
0.13
3.1
3.7
—
—
—
0
0
(4035726)
111
1151
0.96
0.13
1.6
1.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
129
1245
1.04
0.13
3.7
3.9
mmol/l
1.2
1.2
0.03
121
1064
(40768795) Lymph node Pathology biopsy report
13
113
1.15
0.13
1.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
14
123
1.14
0.12
1.6
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
10
85
1.18
0.12
1.1
1.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
15
168
0.89
0.12
1.4
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
13
147
0.88
0.11
1.2
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
164
1596
1.03
0.11
4.7
3.9
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
121
1173
1.03
0.11
4.1
4.0
%
0.5
0.9
1.81
31
385
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
27
250
1.08
0.10
1.7
1.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
10
86
1.16
0.10
2.1
2.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
56
534
1.05
0.10
1.2
1.2
iu/ml
77.8
145.4
0.57
14
177
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
16
144
1.11
0.10
1.0
1.0
—
—
—
0
0
(4062490)
11
96
1.15
0.10
1.3
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
891
8964
0.99
0.10
3.8
3.7
pmol/l
15.2
15.1
0.17
811
7853
(3019150) Specific gravity of Urine by Refractometry
285
2892
0.98
0.09
5.4
4.3
kg/l
1.0
1.0
0.04
50
445
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
54
1.11
0.09
1.5
1.4
g/l
1.2
1.0
—
6
54
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
17
155
1.10
0.09
1.7
1.7
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
16
175
0.91
0.08
1.3
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
36
342
1.05
0.07
1.8
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1132
11260
1.01
0.07
4.7
4.1
mmol/l
1.3
1.3
0.11
1054
9857
(3025468) Yersinia sp identified in Specimen by Organism specific culture
17
183
0.93
0.06
1.9
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
17
183
0.93
0.06
1.9
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
11
121
0.91
0.06
1.5
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
17
182
0.93
0.06
1.9
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
169
1667
1.01
0.04
1.2
1.2
u/ml
24.2
11.7
0.68
48
568
(3000330) Specific gravity of Urine by Test strip
83
846
0.98
0.04
3.4
3.8
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
34
327
1.04
0.04
3.5
2.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
20
189
1.06
0.04
1.2
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
112
1101
1.02
0.04
4.3
4.1
%
0.0
0.1
1.51
31
352
(3028271) Lactate [Moles/volume] in Capillary blood
29
279
1.04
0.03
2.6
1.9
mmol/l
1.6
1.7
0.30
29
271
(3037756) Immunofixation for Serum or Plasma
40
411
0.97
0.03
1.4
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
14
131
1.07
0.03
1.2
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
14
131
1.07
0.03
1.2
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
14
131
1.07
0.03
1.2
1.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
21
219
0.96
0.03
1.1
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
61
598
1.02
0.03
1.4
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
31
300
1.03
0.03
1.5
1.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
13
122
1.06
0.02
1.0
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
37
379
0.97
0.02
2.5
2.1
g/l
128.9
126.7
0.22
26
270
(3010421) pH of Blood
44
430
1.02
0.02
4.3
4.8
ph
7.4
7.4
0.02
36
356
(3017354) Segmented neutrophils/100 leukocytes in Blood
18
172
1.05
0.02
2.4
3.9
%
66.0
56.1
—
9
109
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
174
1750
0.99
0.02
1.2
1.2
iu/ml
55.3
37.5
0.53
51
518
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
103
1.07
0.01
1.1
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
21
217
0.97
0.01
1.1
1.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
37
362
1.02
0.01
4.9
5.2
mmol/l
2.5
2.6
0.16
28
248
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
37
377
0.98
0.01
1.8
1.6
—
—
—
0
0
(4034850)
39
397
0.98
0.01
18.3
12.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1114
11139
1.00
0.01
4.9
4.5
mu/l
2.0
2.2
0.65
1032
9787
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
43
436
0.98
0.00
1.3
1.6
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
40
394
1.01
0.00
1.1
1.0
—
2.3
—
0
5
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
12
123
0.97
0.00
1.6
1.2
nmol/l
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
19
192
0.99
0.00
1.3
1.3
u/l
10.5
9.0
0.19
13
152
(3024522) Salmonella sp identified in Specimen by Organism specific culture
18
184
0.98
0.00
1.8
1.4
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
41
405
1.01
0.00
4.1
3.4
mmol/l
1.9
1.6
0.60
41
397
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
18
185
0.97
0.00
1.8
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
17
168
1.01
0.00
1.6
2.0
—
—
—
0
0
(3017704) Immunofixation for Urine
11
106
1.04
0.00
1.4
1.5
—
—
—
0
0
(4146454)
16
164
0.97
0.00
3.1
2.6
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
36
363
0.99
0.00
3.2
2.5
%
16.3
15.7
0.30
18
179
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
18
182
0.99
0.00
1.8
1.3
—
—
—
0
0
(4281824)
11
111
0.99
0.00
1.1
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
10
95
1.05
0.00
1.0
1.6
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
38
385
0.99
0.00
4.3
3.5
mmol/l
8.0
7.7
0.19
38
379
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
6
59
1.02
0.00
1.2
1.1
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
54
0.92
0.00
1.0
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
59
1.02
0.00
1.0
1.1
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
7
0.00
0.00
0.0
2.4
—
1.6
—
0
7
(3034274) Bile acid [Moles/volume] in Serum --fasting
6
60
1.00
0.00
1.0
1.6
umol/l
6.1
15.5
—
6
38
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
5
0.00
0.00
0.0
6.4
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
42.2
—
0
5
(3044242) Glucose [Moles/volume] in Arterial blood
9
96
0.94
0.00
2.0
2.6
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
59
0.85
0.00
1.0
1.8
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
57
0.88
0.00
1.0
1.8
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
55
0.91
0.00
1.0
1.1
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
71
0.98
0.00
1.3
1.2
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
8.0
—
0
9
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
71
0.98
0.00
1.3
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
51
0.98
0.00
2.4
1.9
ug/l
63.8
57.7
—
5
46
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
57
0.88
0.00
1.0
1.8
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
5.8
—
0
7
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
38.6
—
0
9
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
51
0.98
0.00
2.4
2.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
8
88
0.91
0.00
1.0
1.2
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
51
0.98
0.00
2.4
2.3
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
22.5
—
0
9
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint I9_STR_EMBOLIC and mortality.

Females

Parameter HR [95% CI] p-value
I9_STR_EMBOLIC 2.405 [2.14, 2.7] < 0.001
Birth year 0.995 [0.99, 1.0] 0.196

During the follow-up period (1.1.1998 — 31.12.2019), 2865 out of 4903 females with I9_STR_EMBOLIC died.

Males

Parameter HR [95% CI] p-value
I9_STR_EMBOLIC 1.916 [1.72, 2.13] < 0.001
Birth year 0.984 [0.98, 0.99] < 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 3377 out of 6534 males with I9_STR_EMBOLIC died.

Mortality risk

Mortality risk for people of age

years, who have I9_STR_EMBOLIC.

N-year risk Females Males
1 0.166% 0.377%
5 1.3% 1.977%
10 3.466% 4.817%
15 6.705% 9.438%
20 11.651% 15.913%

Relationships between endpoints

↥

Index endpoint: I9_STR_EMBOLIC – Embolic stroke

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data